Ziprasidone hydrochloride and Zolpidem drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ziprasidone hydrochloride (ziprasidone hydrochloride) and Zolpidem (zolpidem tartrate). Common drug interactions include drug withdrawal syndrome among females and peripheral vascular disorder among males.

The phase IV clinical study analyzes what interactions people have when they take Ziprasidone hydrochloride and Zolpidem. It is created by eHealthMe based on reports of 36 people who take the same drugs from the FDA, and is updated regularly.

What is Ziprasidone hydrochloride?

Ziprasidone hydrochloride has active ingredients of ziprasidone hydrochloride. It is often used in bipolar disorder. eHealthMe is studying from 2,001 Ziprasidone hydrochloride users. Check the latest studies of Ziprasidone hydrochloride.

What is Zolpidem?

Zolpidem has active ingredients of zolpidem tartrate. It is often used in insomnia. eHealthMe is studying from 92,695 Zolpidem users. Check the latest studies of Zolpidem.



On Jul, 11, 2026

36 people who take Ziprasidone hydrochloride and Zolpidem together, and have interactions are studied.

Ziprasidone hydrochloride and Zolpidem drug interactions.

What are the common drug interactions of Ziprasidone Hydrochloride and Zolpidem, by gender? *:

female:

  1. Drug withdrawal syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation)
  2. Hallucination (an experience involving the perception of something not present)
  3. Heart rate increased
  4. Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
  5. Overdose
  6. Abnormal behaviour
  7. Body temperature increased
  8. Cyanosis (lack of oxygen in body leads to blue appearance of skin ,mucous membrane nails)
  9. Tremor (trembling or shaking movements in one or more parts of your body)
  10. Blood pressure increased

male:

  1. Peripheral vascular disorder
  2. Drug ineffective
  3. Enuresis (repeated inability to control urination)
  4. Salivary hypersecretion (excess saliva secretion)
  5. Suicide attempt
  6. Anxiety
  7. Loss of consciousness
  8. Mood altered (changes in mood)
  9. Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
  10. Tic (a sudden, repetitive, nonrhythmic motor movement or vocalization involving discrete muscle groups)

What are the common drug interactions of Ziprasidone Hydrochloride and Zolpidem, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Blood prolactin increased
  2. Depression
  3. Drug ineffective
  4. Electrocardiogram qt prolonged
  5. Galactorrhoea (secretion of breast milk in men)
  6. Lethargy (tiredness)
  7. Suicidal ideation
  8. Weight increased

20-29:

  1. Constipation
  2. Drug ineffective
  3. Enuresis (repeated inability to control urination)
  4. Salivary hypersecretion (excess saliva secretion)
  5. Suicide attempt
  6. Cardio-respiratory arrest (sudden dysfunction of heart and lungs)

30-39:

  1. Aggression
  2. Agitation (state of anxiety or nervous excitement)
  3. Drug ineffective
  4. Malabsorption (a state arising from abnormality in absorption of food nutrients across the gastrointestinal (gi) tract)
  5. Psychiatric symptom
  6. Sinus disorder (disease of sinus)
  7. Somnolence (a state of near-sleep, a strong desire for sleep)

40-49:

  1. Drug withdrawal syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation)
  2. Hallucination (an experience involving the perception of something not present)
  3. Heart rate increased
  4. Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
  5. Overdose
  6. Abnormal behaviour
  7. Body temperature increased
  8. Cyanosis (lack of oxygen in body leads to blue appearance of skin ,mucous membrane nails)
  9. Tremor (trembling or shaking movements in one or more parts of your body)
  10. Blood pressure increased

50-59:

  1. Peripheral vascular disorder
  2. Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
  3. Depression
  4. Disorientation (disability in which the senses of time, direction, and recognition of people and places)
  5. Drug ineffective
  6. Extrapyramidal disorder (involuntary muscle spasms in the face and neck)
  7. Parkinsonism (degenerative disorder of the central nervous system characterized by tremor and impaired muscular coordination)
  8. Psychotic disorder
  9. Therapeutic response decreased (less preventive response)
  10. Visual acuity reduced (reduced clearness of vision)

60+:

  1. Weight increased
  2. Anxiety
  3. Suicidal ideation
  4. Tic (a sudden, repetitive, nonrhythmic motor movement or vocalization involving discrete muscle groups)
  5. Adverse drug reaction
  6. Increased appetite
  7. Blood prolactin increased
  8. Depression
  9. Electrocardiogram qt prolonged
  10. Galactorrhoea (secretion of breast milk in men)

What are the existing conditions these people have? *

  1. Hiv Infection: 6 people, 16.67%
  2. Schizoaffective Disorder (a mental disorder characterized by disordered thought): 5 people, 13.89%
  3. Bedwetting: 3 people, 8.33%
  4. Stress And Anxiety: 2 people, 5.56%
  5. Gilles De La Tourette Syndrome (a condition that causes people to make repeated, quick movements or sounds that they cannot control): 2 people, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Ziprasidone hydrochloride and Zolpidem?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Ziprasidone hydrochloride and Zolpidem:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ziprasidone hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Zolpidem:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ziprasidone hydrochloride and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Zolpidem and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on ziprasidone hydrochloride and zolpidem tartrate (the active ingredients of Ziprasidone hydrochloride and Zolpidem, respectively), and Ziprasidone hydrochloride and Zolpidem (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: